MAIA Biotechnology Inc (MAIA)
2.93
0.00 (0.00%)
USD |
NYAM |
May 01, 16:00
2.93
0.00 (0.00%)
After-Hours: 16:27
MAIA Biotechnology Cash from Operations (TTM): -13.07M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -13.07M |
September 30, 2023 | -12.03M |
June 30, 2023 | -13.19M |
March 31, 2023 | -12.65M |
December 31, 2022 | -12.10M |
Date | Value |
---|---|
September 30, 2022 | -10.75M |
June 30, 2022 | -7.746M |
March 31, 2022 | -6.677M |
December 31, 2021 | -4.123M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-13.19M
Minimum
Jun 2023
-4.123M
Maximum
Dec 2021
-10.26M
Average
-12.03M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
Cyclacel Pharmaceuticals Inc | -16.11M |
Avid Bioservices Inc | 12.68M |
Oragenics Inc | -7.291M |
NeuBase Therapeutics Inc | -14.78M |
Viking Therapeutics Inc | -54.87M |